Brief: Kyverna Therapeutics Inc Strong Balance Sheet Extends Cash Runway Into 2027 Through Key Clinical And Regulatory Catalysts
27/03/2025 21:03
March 27 (Reuters) - Kyverna Therapeutics Inc KYTX.O: KYVERNA THERAPEUTICS INC: STRONG BALANCE SHEET EXTENDS CASH RUNWAY INTO 2027 THROUGH KEY CLINICAL AND REGULATORY CATALYSTS Source text: ID:nPnbDCXkja Further company coverage: KYTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kyverna Therapeutics
See all newsHealth Rounds: Appendix removal linked with lower colon cancer risk in study
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry
U.S. STOCKS ON THE MOVE-Everpure, Dropbox, Darden Restaurants